Among adult lymphoma survivors, radiation treatment techniques that increase the excess
radiation dose to organs at risk (OARs) put patients at risk for increased side effects …

PURPOSE: To evaluate the potential of three-dimensional proton beam therapy (3D-PBT)
for reducing doses to normal structures in patients with mediastinal lymphomas compared …

Proton therapy was first suggested in the management of lymphoma in 1974 as a way to
spare the bone marrow when treating total nodal fields (1). However, interest in its use in …

Background: Late effects induced by radiotherapy (RT) are of great concern for mediastinal
Hodgkin's lymphoma (HL) patients and it is therefore important to reduce normal tissue …

PURPOSE: To compare the dose reduction to organs at risk (OARs) with proton therapy (PT)
versus three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated …

BACKGROUND Mediastinal recurrence remains the most common cause of failure in
patients with mediastinal T‐cell lymphoblastic lymphoma (LBL). The role of mediastinal …

Background and purpose Due to the long life expectancy after treatment, the risk of late
effects after radiotherapy (RT) is of particular importance for patients with Hodgkin …

Background We investigated early outcomes for patients receiving chemotherapy followed
by consolidative proton therapy (PT) for the treatment of Hodgkin lymphoma (HL). Patients …

PURPOSE: Cure rates of early Hodgkin lymphoma (HL) are high, and avoidance of late
complications and second malignancies have become increasingly important. This …

Purpose: To determine the feasibility, potential advantage, and indications for intensity-
modulated radiotherapy (IMRT) in the treatment of Hodgkin's lymphoma or non-Hodgkin's …